Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
Stock Split Ex Date
Annual Dividend Yield
Quarterly Dividend Rate
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Check out the Symbol Surfing blog to learn about investing.